Two Sigma Investments, LP Aspira Women'S Health Inc. Transaction History

Two Sigma Investments, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.4 - $1.09 $16,313 - $44,453	-40,783 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$0.88 - $1.81 $308,957 - $635,469	-351,088 Reduced 89.59%	40,783 $42,000
Q4 2021 Feb 14, 2022	BUY	$1.63 - $3.43 $430,157 - $905,177	263,900 Added 206.22%	391,871 $694,000
Q3 2021 Nov 15, 2021	BUY	$3.19 - $5.48 $293,068 - $503,453	91,871 Added 254.49%	127,971 $416,000
Q2 2021 Aug 16, 2021	BUY	$4.78 - $6.84 $172,558 - $246,924	36,100 New	36,100 $203,000

431K

Ticker AWH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 124,296,000
Market Cap $123M
Description
Aspira Women's Health Inc., together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. The company provides OVA1, OVERA, and OVA1plus to detect risk of ovarian malignancy in women with adnexal masses. It also offers ASPiRA GenetiX, a genetic test for the risk of gyneco...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.